Deutsche Bank Ag\ Gritstone Bio, Inc. Transaction History

Deutsche Bank Ag\

$218 Billion
Q2 2024

A detailed history of Deutsche Bank Ag\ transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 3,228,972 shares of GRTS stock, worth $96,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,228,972

Previous 2,980,015 8.35%

Holding current value

$96,869

Previous $7.66 Million 73.87%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.62 - $2.35 $154,353 - $585,048	248,957 Added 8.35%	3,228,972 $2 Million
Q1 2024 May 15, 2024	BUY	$1.96 - $2.9 $5.84 Million - $8.64 Million	2,980,015 New	2,980,015 $7.66 Million
Q3 2023 Nov 09, 2023	BUY	$1.19 - $2.26 $59,345 - $112,706	49,870 New	49,870 $85,000
Q2 2022 Aug 11, 2022	BUY	$1.77 - $4.34 $68,288 - $167,441	38,581 Added 47.59%	119,645 $290,000
Q1 2022 May 13, 2022	BUY	$4.03 - $12.19 $125,461 - $379,499	31,132 Added 62.35%	81,064 $334,000
Q4 2021 Feb 11, 2022	SELL	$8.76 - $13.71 $1.31 Million - $2.04 Million	-148,992 Reduced 74.9%	49,932 $642,000
Q3 2021 Nov 04, 2021	SELL	$6.41 - $13.54 $3.96 Million - $8.36 Million	-617,135 Reduced 75.62%	198,924 $2.15 Million
Q2 2021 Aug 11, 2021	BUY	$8.13 - $10.2 $6.46 Million - $8.11 Million	794,984 Added 3772.17%	816,059 $7.45 Million
Q1 2021 May 13, 2021	SELL	$4.07 - $27.11 $448,872 - $2.99 Million	-110,288 Reduced 83.96%	21,075 $198,000
Q4 2020 Feb 16, 2021	SELL	$2.57 - $4.22 $55,828 - $91,671	-21,723 Reduced 14.19%	131,363 $517,000
Q3 2020 Nov 12, 2020	BUY	$2.63 - $8.09 $73,426 - $225,864	27,919 Added 22.31%	153,086 $406,000
Q2 2020 Aug 13, 2020	BUY	$5.69 - $8.17 $388,729 - $558,158	68,318 Added 120.17%	125,167 $831,000
Q1 2020 May 14, 2020	SELL	$5.47 - $11.3 $2,778 - $5,740	-508 Reduced 0.89%	56,849 $331,000
Q4 2019 Feb 14, 2020	BUY	$7.07 - $11.61 $75,005 - $123,170	10,609 Added 22.69%	57,357 $513,000
Q3 2019 Nov 14, 2019	BUY	$8.45 - $12.28 $64,879 - $94,285	7,678 Added 19.65%	46,748 $402,000
Q2 2019 Aug 14, 2019	BUY	$9.2 - $15.7 $95,137 - $162,353	10,341 Added 35.99%	39,070 $433,000
Q1 2019 May 15, 2019	SELL	$9.97 - $18.96 $3,260 - $6,199	-327 Reduced 1.13%	28,729 $381,000
Q4 2018 Feb 14, 2019	BUY	$11.61 - $31.1 $337,340 - $903,641	29,056 New	29,056 $448,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

37.5M

Call Options Held

1.46M

Put Options Held

168K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account